Macular disease

A former backpacker accommodation is being transformed into a new eye health clinic in Broome, featuring three resident ophthalmologists available...

A surgeon at the University of Pittsburgh Medical Center (UPMC) has implanted the first patient in the US with a...

A Melbourne researcher has received a major funding boost to progress development of a tissue-engineered corneal endothelium for transplant, which...

In a discovery that could have significant implications for how age-related ocular diseases are diagnosed and treated, researchers have pinpointed...

A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients...

Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the...

Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic...

An Australian-led study has received $5 million to undertake the world’s most intensive investigation into why a particular group of...

Novartis’ new therapy for neovascular age-related macular degeneration (nAMD) has advanced part-way through the European regulatory process after winning the...

Inconsistent or ineffective age-related macular degeneration (AMD) treatments might be solved by an easy solution, according to new research from...